Jiangsu Lianhuan Pharmaceutical (600513.SH) subsidiary Aisizolun tablets passed consistency evaluation.

Jiangsu Lianhuan Pharmaceutical (600513.SH) announced that its controlling subsidiary, Xinxiang Changle Pharmaceutical Co., Ltd. ("Changle Pharmaceutical"), recently received the approval notice from the National Medical Products Administration for the supplementary application for the production of Alprazolam Tablets. This approval allows Changle Pharmaceutical's product to pass the generic drug quality and efficacy consistency assessment. Alprazolam Tablets are mainly used for anti-anxiety and insomnia, as well as for tension, fear, anti-epileptic, and anti-convulsive purposes. This drug is a commonly used benzodiazepine sedative-hypnotic medication in clinical practice.